Koyfin Home > Directory > Health Care > Amicus Therapeutics > Cash from Financing Activities

Amicus Therapeutics Cash from Financing Activities Chart (FOLD)

Amicus Therapeutics annual/quarterly Cash from Financing Activities from 2006 to 2018.
  • Amicus Therapeutics Cash from Financing Activities for the quarter ending September 09, 2018 was $147m a 95.32% increase of 140m year over year
  • Amicus Therapeutics Cash from Financing Activities for the last 12 months ending September 09, 2018 was $457m a 45.89% increase of 210m year over year
  • Amicus Therapeutics Annual Cash from Financing Activities for 2017 was $247m a -10.22% decrease of -25m from 2016
  • Amicus Therapeutics Annual Cash from Financing Activities for 2016 was $273m a -6.67% decrease of -18m from 2015
  • Amicus Therapeutics Annual Cash from Financing Activities for 2015 was $291m a 52.15% increase of 152m from 2014
Other Cash Flow Metrics:
  • Amicus Therapeutics Cash Flow from Operations for the quarter ending September 09, 2018 was $-133m a 44.44% decrease of -59m year over year
  • Amicus Therapeutics Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-78m a 35.32% decrease of -28m year over year
  • Amicus Therapeutics Total Revenue for the quarter ending September 09, 2018 was $21m a 28.49% increase of 6m year over year
View Chart On Koyfin

Quarterly FOLD Cash from Financing Activities Data

09/2018$147m
06/2018$7m
03/2018$297m
12/2017$7m
09/2017$250m
06/2017$-10m
03/2017$0m
12/2016$150m
09/2016$40m
06/2016$83m

Annual FOLD Cash from Financing Activities Data

2017$247m
2016$273m
2015$291m
2014$139m
2013$29m
2012$81m
2011$-1m
2010$44m
2009$3m
2008$-1m